Interim Update

NMT Group PLC
14 October 2002

14 October 2002

                                 NMT Group PLC

                                 Interim Update



NMT Group, the manufacturer of retractable devices to prevent needlestick
injury, announces today:-



Key points

•         Signing of a Global Supply Agreement with Roche for supply of 1cc and
3cc retractable safety syringes. The syringes will be packaged alongside Roche's
Fuzeon(R), a revolutionary drug for the treatment of HIV.

•         Livingston manufacturing facility recommences production of 1st
Generation syringe product as a result of Roche contract.

•         Discussions with potential partners for the licensing of 2nd
Generation syringe technology are ongoing.

•         NMT to focus commercial and product development efforts in
pharmaceutical sector

•         Strong financial position - cash balance at 30 September 2002 £17m.



Commenting on the results, Roy Smith, Chief Executive Officer, said:



'I am delighted that we have reached agreement with Roche, one of the world's
leading pharmaceutical companies, for the supply of our retractable syringes.
This agreement represents a significant milestone in the history of NMT, and
should create a platform on which we can achieve further commercial success. I
am equally pleased that the result of this contract will allow recommencement of
production at our Livingston facility and our staff, who deserve this success,
can now focus on increased output over a sustainable period.  On the strength of
this Agreement we will increase our commercial and product development focus
within the pharmaceutical sector where, I believe, our current intellectual
property can create real value.



'I also remain encouraged at the level of interest which we are receiving from
large medical device companies in the licensing of our second generation syringe
technology for the Acute Hospital market, particularly in the US, where
discussions with potential partners are ongoing.'



Enquiries:


NMT Group PLC
Roy Smith, Chief Executive Officer                            Tel: [phone]
Gerard Cassels, Finance Director                              Tel: [phone]

Financial Dynamics                                            Tel: [phone]
Fiona Noblet




                      This information is provided by RNS
            The company news service from the London Stock Exchange